Skyhawk Therapeutics

Skyhawk Therapeutics

Biotechnology Research

Waltham, Massachusetts 9,535 followers

We Use Small Molecules To Modify RNA Splicing

About us

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Waltham, Massachusetts
Type
Privately Held
Founded
2016

Locations

  • Primary

    180 3rd Ave., Sixth Floor

    Waltham, Massachusetts 02451, US

    Get directions

Employees at Skyhawk Therapeutics

Updates

Similar pages

Browse jobs

Funding

Skyhawk Therapeutics 6 total rounds

Last Round

Series unknown

US$ 133.0M

Investors

Fidelity
See more info on crunchbase